Process for the preparation of repaglinide

Patent 7148355 Issued on December 12, 2006. Estimated Expiration Date:

September 24, 2022. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Abstract Claims Description Full Text

Patent References

Phenylacetic acid benzylamides Patent #: 5312924
Issued on: 05/17/1994
Inventor: Grell, et al.

Inventors

Assignee

Ranbaxy Laboratories Limited

Application

No. 10490275 filed on 09/24/2002

US Classes:

546/234Plural carbocyclic rings containing

Examiners

Primary: Morris, Patricia L.

Attorney, Agent or Firm

Deshmukh, Esq.; Jayadeep R.

International Class

C07D 211/32

Abstract

The present invention relates to a cost effective and industrially advantageous process for the preparation of repaglinide.

Other References

Grell et al., “Repaglinide and Related Hypoglycemic Benzoic Acid Derivatives”, Journal of Medicinal Chemistry, 41:5219-5246 (1998) XP000872800, ISSN # 0022-2623.
Guay, “Repaglinide, a Novel, Short-Acting Hypoglycemic Agent for Type 2 Diabetes Mellitus”, Pharmacotherapy, 18(6):1195-1204 (1998) XP000874581, ISSN # 0277-0008.
Patent Abstracts of Japan, vol. 008, No. 168 (C-236) (1984) & Pat. JP 59-065094A—Abstract.